Is the Fixed-Dose Intravenous Trastuzumab Policy Warranted in Limited-Resource Settings?

Detalles Bibliográficos
Autores principales: Kassem, Loay, Shohdy, Kyrillus S., Abdel-Azeez, Ahmad M., Attia, Hanaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426478/
https://www.ncbi.nlm.nih.gov/pubmed/30676841
http://dx.doi.org/10.1200/JGO.18.00155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426478/
https://www.ncbi.nlm.nih.gov/pubmed/30676841
http://dx.doi.org/10.1200/JGO.18.00155

Ejemplares similares